{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:18:05Z","timestamp":1760314685554,"version":"build-2065373602"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1016\/j.jaut.2006.06.003","type":"journal-article","created":{"date-parts":[[2006,8,9]],"date-time":"2006-08-09T08:34:17Z","timestamp":1155112457000},"page":"62-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Genetically determined imbalance between serum levels of tumour necrosis factor (TNF) and interleukin (IL)-10 is associated with anti-Jo-1 and anti-Ro52 autoantibodies in patients with poly- and dermatomyositis"],"prefix":"10.1016","volume":"27","author":[{"given":"Adla B.","family":"Hassan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Fathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Dastmalchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid E.","family":"Lundberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonid","family":"Padyukov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2006.06.003_bib1","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1056\/NEJM199111213252107","article-title":"Polymyositis, dermatomyositis and inclusion-body myositis","volume":"325","author":"Dalakas","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaut.2006.06.003_bib2","first-page":"925","article-title":"The Jo-1 antibody system in myositis: relationships to clinical features and HLA","volume":"8","author":"Arnett","year":"1981","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.jaut.2006.06.003_bib3","first-page":"353","article-title":"Interstitial lung disease in polymyositis and dermatomyositis","volume":"7","author":"Songcharoen","year":"1980","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaut.2006.06.003_bib4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/ard.46.1.23","article-title":"Pulmonary disease in polymyositis\/dermatomyositis: a clinicopathological analysis of 65 autopsy cases","volume":"46","author":"Lakhanpal","year":"1987","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2006.06.003_bib5","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/art.1780140210","article-title":"Factors affecting survivorship in polymyositis. A life-table study of 124 patients","volume":"14","author":"Medsger","year":"1971","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2006.06.003_bib6","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00005792-199111000-00002","article-title":"A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups","volume":"70","author":"Love","year":"1991","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaut.2006.06.003_bib7","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/00002281-200011000-00001","article-title":"Update on myositis-specific and myositis-associated autoantibodies","volume":"12","author":"Targoff","year":"2000","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jaut.2006.06.003_bib8","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/00002281-200111000-00004","article-title":"Myositis-specific autoantibodies: overview and recent developments","volume":"13","author":"Hengstman","year":"2001","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jaut.2006.06.003_bib9","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/art.1780350718","article-title":"Antibodies to glycyl-transfer RNA synthetase in patients with myositis and interstitial lung disease","volume":"35","author":"Targoff","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2006.06.003_bib10","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1183\/09031936.97.10122907","article-title":"Pulmonary fibrosis with predominant CD8 lymphocytic alveolitis and anti-Jo-1 antibodies","volume":"10","author":"Sauty","year":"1997","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaut.2006.06.003_bib11","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/art.20208","article-title":"Association of the proinflammatory haplotype (MICA5.1\/TNF2\/TNFa2\/DRB1*03) with polymyositis and dermatomyositis","volume":"50","author":"Hassan","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2006.06.003_bib12","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0198-8859(01)00264-6","article-title":"A genetically determined high setting of TNF-alpha influences immunologic parameters of HLA-B8,DR3 positive subjects: implications for autoimmunity","volume":"62","author":"Lio","year":"2001","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jaut.2006.06.003_bib13","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1084\/jem.181.3.839","article-title":"Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus","volume":"181","author":"Llorente","year":"1995","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaut.2006.06.003_bib14","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/art.1780400514","article-title":"Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies","volume":"40","author":"Lundberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2006.06.003_bib15","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1097\/00007890-199810270-00009","article-title":"Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation","volume":"66","author":"Awad","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.jaut.2006.06.003_bib16","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/ard.2003.006122","article-title":"Interstitial lung disease, a common manifestation of newly diagnosed polymyositis and dermatomyositis","volume":"63","author":"Fathi","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2006.06.003_bib17","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1136\/thx.52.5.442","article-title":"Relative production of tumour necrosis factor alpha and interleukin 10 in adult respiratory distress syndrome","volume":"52","author":"Armstrong","year":"1997","journal-title":"Thorax"},{"key":"10.1016\/j.jaut.2006.06.003_bib18","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S0140-6736(05)60606-X","article-title":"Anti-inflammatory cytokine profile and mortality in febrile patients","volume":"351","author":"van Dissel","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2006.06.003_bib19","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1046\/j.1365-2249.1999.00865.x","article-title":"IL-10 in HIV infection: increasing serum IL-10 levels with disease progression\u2013down-regulatory effect of potent anti-retroviral therapy","volume":"116","author":"Stylianou","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaut.2006.06.003_bib20","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1086\/315214","article-title":"Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options","volume":"181","author":"Gogos","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaut.2006.06.003_bib21","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1086\/315857","article-title":"Plasma interleukin-10:Tumor necrosis factor (TNF)-alpha ratio is associated with TNF promoter variants and predicts malarial complications","volume":"182","author":"May","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaut.2006.06.003_bib22","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1128\/CDLI.8.6.1164-1170.2001","article-title":"Anemia and interleukin-10, tumor necrosis factor alpha, and erythropoietin levels among children with acute, uncomplicated Plasmodium falciparum malaria","volume":"8","author":"Nussenblatt","year":"2001","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.jaut.2006.06.003_bib23","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.atherosclerosis.2004.07.026","article-title":"The A-1087IL-10 allele is associated with cardiovascular disease in SLE","volume":"177","author":"Fei","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jaut.2006.06.003_bib24","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/hmg\/1.5.353","article-title":"Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product","volume":"1","author":"Wilson","year":"1992","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jaut.2006.06.003_bib25","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1046\/j.1365-3083.1996.d01-65.x","article-title":"Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease","volume":"43","author":"Bouma","year":"1996","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.jaut.2006.06.003_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2370.1997.tb00001.x","article-title":"An investigation of polymorphism in the interleukin-10 gene promoter","volume":"24","author":"Turner","year":"1997","journal-title":"Eur J Immunogenet"},{"key":"10.1016\/j.jaut.2006.06.003_bib27","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1600-065X.1999.tb01398.x","article-title":"The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases","volume":"167","author":"Price","year":"1999","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaut.2006.06.003_bib28","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1084\/jem.177.2.557","article-title":"An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles","volume":"177","author":"Wilson","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaut.2006.06.003_bib29","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaut.2006.06.003_bib30","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis (second of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaut.2006.06.003_bib31","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1080\/030097401753180363","article-title":"Longitudinal study of interleukin-10, tumor necrosis factor-alpha, anti-U1-snRNP antibody levels and disease activity in patients with mixed connective tissue disease","volume":"30","author":"Hassan","year":"2001","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.jaut.2006.06.003_bib32","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/sj.gene.6363771","article-title":"Different allelic frequencies of several cytokine genes in Hong Kong Chinese and Swedish Caucasians","volume":"2","author":"Padyukov","year":"2001","journal-title":"Genes Immun"},{"key":"10.1016\/j.jaut.2006.06.003_bib33","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0198-8859(02)00776-0","article-title":"MICA4\/HLA-DRB1*04\/TNF1 haplotype is associated with mixed connective tissue disease in Swedish patients","volume":"64","author":"Hassan","year":"2003","journal-title":"Hum Immunol"},{"year":"2000","series-title":"A Software for population genetic data analysis","author":"Schneider","key":"10.1016\/j.jaut.2006.06.003_bib34"},{"key":"10.1016\/j.jaut.2006.06.003_bib35","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0165-5728(95)00122-0","article-title":"Analysis of cytokine expression in muscle in inflammatory myopathies, Duchenne dystrophy, and non-weak controls","volume":"63","author":"Lundberg","year":"1995","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jaut.2006.06.003_bib36","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0022-510X(96)00280-8","article-title":"Expression of tumor necrosis factor-alpha in muscles of polymyositis","volume":"146","author":"Tateyama","year":"1997","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.jaut.2006.06.003_bib37","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1002\/1529-0131(200010)43:10<2368::AID-ANR26>3.0.CO;2-8","article-title":"TNFalpha-308A allele in juvenile dermatomyositis: association with increased production of tumor necrosis factor alpha, disease duration, and pathologic calcifications","volume":"43","author":"Pachman","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2006.06.003_bib38","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1600-0897.2004.00177.x","article-title":"Gender difference in the non-specific and specific immune response in humans","volume":"52","author":"Bouman","year":"2004","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.jaut.2006.06.003_bib39","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1046\/j.1365-2249.2001.01495.x","article-title":"Gender-dependent specific immune response during chronic human Schistosomiasis haematobia","volume":"124","author":"Remoue","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaut.2006.06.003_bib40","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/00024382-200116050-00003","article-title":"Gender differences in cytokine secretion by human peripheral blood mononuclear cells: role of estrogen in modulating LPS-induced cytokine secretion in an ex vivo septic model","volume":"16","author":"Asai","year":"2001","journal-title":"Shock"},{"key":"10.1016\/j.jaut.2006.06.003_bib41","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000079547","article-title":"Treatment of dermatomyositis and polymyositis with anti-tumor necrosis factor-alpha: long-term follow-up","volume":"52","author":"Hengstman","year":"2004","journal-title":"Eur Neurol"},{"key":"10.1016\/j.jaut.2006.06.003_bib42","doi-asserted-by":"crossref","unstructured":"P. Efthimiou, S. Schwartzman, L. Kagen, 2006. Possible role for TNF-inhibitors in the treatment of resistant dermatomyositis and polymyositis. Ann Rheum Dis, in press. doi: 10.1136\/ard.2005.048744.","DOI":"10.1136\/ard.2005.048744"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841106000473?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841106000473?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T07:57:17Z","timestamp":1760255837000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841106000473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S0896841106000473"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2006.06.003","relation":{},"ISSN":["0896-8411"],"issn-type":[{"type":"print","value":"0896-8411"}],"subject":[],"published":{"date-parts":[[2006,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetically determined imbalance between serum levels of tumour necrosis factor (TNF) and interleukin (IL)-10 is associated with anti-Jo-1 and anti-Ro52 autoantibodies in patients with poly- and dermatomyositis","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2006.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}